COMPANY PROFILE / #2849
Acelot
San Francisco, CAVenture Capital-Backed
OVERVIEW
Operator of a biopharmaceutical company intended for drug discovery. The company's joint pharmacophore space technology utilizes a 3D pharmacophore analysis method to predict drug-relevant properties with accuracy and develops target therapies with a high degree of therapeutic predictability, enabling physicians to discover novel treatments for Alzheimer's Disease and central nervous system disorders.
已融资24.17
最新估值48.20
员工数14
成立年份2006
公司概况
- Companies
- Acelot
- Description
- Operator of a biopharmaceutical company intended for drug discovery. The company's joint pharmacophore space technology utilizes a 3D pharmacophore analysis method to predict drug-relevant properties with accuracy and develops target therapies with a high degree of therapeutic predictability, enabling physicians to discover novel treatments for Alzheimer's Disease and central nervous system disorders.
- Website
- www.acelot.com
- HQ Location
- San Francisco, CA
- Year Founded
- 2006
- Keywords
- alzheimer drugs, alzheimer's disease detection, biopharmaceutical company operator, biotechnology research, drug discovery system, therapeutic mechanism
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 24.17
- First Financing Date
- 01-Jan-2006
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 10-Jul-2025
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 8.70
- Last Financing Valuation
- 48.20
- Last Financing Status
- Completed
- Last Known Valuation
- 48.20
- Last Known Valuation Date
- 10-Jul-2025
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 72.58
- Valuation Estimate Growth Rate
- 50.59%
- Active Investors
- California Life Sciences, U.S. Department of Health and Human Services, University of California, Santa Barbara, US National Science Foundation
- # Active Investors
- 4
- Acquirers
- —
团队与联系人
- Employees
- 14
- Employee Growth %
- 16.67% E
- Employee History
- 2023: 14, 2022: 12 E, 2021: 10 E, 2020: 8 E, 2019: 6 E, 2018: 4 E, 2017: 2
- Primary Contact
- Christian Lang
- Primary Contact Title
- Chief Technology Officer
- Primary Contact Email
- clang@viqiai.com
- Primary Contact Phone
- +1 (805) 895-3610
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- —
- Growth Rate % Change
- —
- Growth Rate Percentile
- —
- Size Multiple
- —
- Size Multiple % Change
- —
- Size Multiple Change
- —
- Size Multiple Percentile
- —
- Majestic Referring Domains
- —
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 3%
- Success Probability Over Time – 3 Year
- 18%
- Success Probability Over Time – 5 Year
- 23%
记录来源：public.companies · 原始序号 #2849 · 所有字段均按数据库原值展示。